{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:15:59Z","timestamp":1791148559301,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T00:00:00Z","timestamp":1350950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10552-012-0089-5","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:49:57Z","timestamp":1350866997000},"page":"55-60","source":"Crossref","is-referenced-by-count":47,"title":["The association between cancer and amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"24","author":[{"given":"D. Michal","family":"Freedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle E.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Goedert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph W.","family":"Kuncl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,23]]},"reference":[{"key":"89_CR1","doi-asserted-by":"crossref","first-page":"e1001257","DOI":"10.1371\/journal.pgen.1001257","volume":"6","author":"H Plun-Favreau","year":"2010","unstructured":"Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW (2010) Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 6:e1001257","journal-title":"PLoS Genet"},{"key":"89_CR2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1470-2045(11)70041-9","volume":"12","author":"R Tabares-Seisdedos","year":"2011","unstructured":"Tabares-Seisdedos R, Dumont N, Baudot A et al (2011) No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol 12:604\u2013608","journal-title":"Lancet Oncol"},{"key":"89_CR3","doi-asserted-by":"crossref","unstructured":"Devine MJ, Plun-Favreau H, Wood NW (2011) Parkinson\u2019s disease and cancer: two wars, one front. Nat Rev Cancer 11:812\u2013823","DOI":"10.1038\/nrc3150"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e3181c91873","volume":"74","author":"CM Roe","year":"2010","unstructured":"Roe CM, Fitzpatrick AL, Xiong C et al (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74:106\u2013112","journal-title":"Neurology"},{"key":"89_CR5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","volume":"21","author":"A Bajaj","year":"2010","unstructured":"Bajaj A, Driver JA, Schernhammer ES (2010) Parkinson\u2019s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 21:697\u2013707","journal-title":"Cancer Causes Control"},{"key":"89_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","volume":"92","author":"JH Olsen","year":"2005","unstructured":"Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L, Moller H (2005) Atypical cancer pattern in patients with Parkinson\u2019s disease. Br J Cancer 92:201\u2013205","journal-title":"Br J Cancer"},{"key":"89_CR7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1055-9965.EPI-07-0038","volume":"16","author":"JA Driver","year":"2007","unstructured":"Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T (2007) A prospective cohort study of cancer incidence following the diagnosis of Parkinson\u2019s disease. Cancer Epidemiol Biomarkers Prev 16:1260\u20131265","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"89_CR8","doi-asserted-by":"crossref","first-page":"e1442","DOI":"10.1136\/bmj.e1442","volume":"344","author":"JA Driver","year":"2012","unstructured":"Driver JA, Beiser A, Au R et al (2012) Inverse association between cancer and Alzheimer\u2019s disease: results from the Framingham Heart Study. BMJ 344:e1442","journal-title":"BMJ"},{"key":"89_CR9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.ede.0000229445.90471.5e","volume":"17","author":"JH Olsen","year":"2006","unstructured":"Olsen JH, Friis S, Frederiksen K (2006) Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 17:582\u2013587","journal-title":"Epidemiology"},{"key":"89_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000087447","volume":"25","author":"DM Freedman","year":"2005","unstructured":"Freedman DM, Travis LB, Gridley G, Kuncl RW (2005) Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors. Neuroepidemiology 25:176\u2013180","journal-title":"Neuroepidemiology"},{"key":"89_CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000097851","volume":"28","author":"PD Baade","year":"2007","unstructured":"Baade PD, Fritschi L, Freedman DM (2007) Mortality due to amyotrophic lateral sclerosis and Parkinson\u2019s disease among melanoma patients. Neuroepidemiology 28:16\u201320","journal-title":"Neuroepidemiology"},{"key":"89_CR12","first-page":"159","volume":"55","author":"J Zisfein","year":"1988","unstructured":"Zisfein J, Caroscio JT (1988) No association of amyotrophic lateral sclerosis with cancer. Mt Sinai J Med 55:159\u2013161","journal-title":"Mt Sinai J Med"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00314238","volume":"235","author":"A Chio","year":"1988","unstructured":"Chio A, Brignolio F, Meineri P, Rosso MG, Tribolo A, Schiffer D (1988) Motor neuron disease and malignancies: results of a population-based study. J Neurol 235:374\u2013375","journal-title":"J Neurol"},{"key":"89_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.30.5.453","volume":"30","author":"JF Kurtzke","year":"1980","unstructured":"Kurtzke JF, Beebe GW (1980) Epidemiology of amyotrophic lateral sclerosis: 1. A case\u2013control comparison based on ALS deaths. Neurology 30:453\u2013462","journal-title":"Neurology"},{"key":"89_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000110872","volume":"3","author":"K Kondo","year":"1984","unstructured":"Kondo K (1984) Motor neuron disease and Parkinson\u2019s disease are not associated with other disorders at autopsy. Neuroepidemiology 3:182\u2013194","journal-title":"Neuroepidemiology"},{"key":"89_CR16","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688\u20131700","journal-title":"N Engl J Med"},{"key":"89_CR17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942\u2013955","journal-title":"Lancet"},{"key":"89_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","volume":"79","author":"G Logroscino","year":"2008","unstructured":"Logroscino G, Traynor BJ, Hardiman O et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79:6\u201311","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"89_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000306055","volume":"35","author":"K Steenland","year":"2010","unstructured":"Steenland K, MacNeil J, Seals R, Levey A (2010) Factors affecting survival of patients with neurodegenerative disease. Neuroepidemiology 35:28\u201335","journal-title":"Neuroepidemiology"},{"key":"89_CR20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/jnnp.2009.201251","volume":"81","author":"FJ Mateen","year":"2010","unstructured":"Mateen FJ, Carone M, Sorenson EJ (2010) Patients who survive 5\u00a0years or more with ALS in Olmsted County, 1925\u20132004. J Neurol Neurosurg Psychiatry 81:1144\u20131146","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"89_CR21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio A, Logroscino G, Hardiman O et al (2009) Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 10:310\u2013323","journal-title":"Amyotroph Lateral Scler"},{"key":"89_CR22","volume-title":"New malignancies among cancer survivors: SEER cancer registries, 1973\u20132000","author":"RE Curtis","year":"2006","unstructured":"Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr (2006) New malignancies among cancer survivors: SEER cancer registries, 1973\u20132000. National Cancer Institute, Bethesda"},{"key":"89_CR23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1282::AID-CNCR3>3.0.CO;2-L","volume":"83","author":"J Swan","year":"1998","unstructured":"Swan J, Wingo P, Clive R et al (1998) Cancer surveillance in the U.S.: can we have a national system? Cancer 83:1282\u20131291","journal-title":"Cancer"},{"key":"89_CR24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1212\/WNL.37.8.1339","volume":"37","author":"M Leone","year":"1987","unstructured":"Leone M, Chandra V, Schoenberg BS (1987) Motor neuron disease in the United States, 1971 and 1973\u20131978: patterns of mortality and associated conditions at the time of death. Neurology 37:1339\u20131343","journal-title":"Neurology"},{"key":"89_CR25","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","volume":"344","author":"MJ Barry","year":"2001","unstructured":"Barry MJ (2001) Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 344:1373\u20131377","journal-title":"N Engl J Med"},{"key":"89_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000321177","volume":"35","author":"PD Baade","year":"2010","unstructured":"Baade PD, Herrero Hernandez E, Freedman DM, Smithers BM, Fritschi L (2010) No role for melanoma treatment in the association between melanoma and amyotrophic lateral sclerosis or Parkinson\u2019s disease. Neuroepidemiology 35:303\u2013304","journal-title":"Neuroepidemiology"},{"key":"89_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728214.2011.604312","volume":"16","author":"AA Habib","year":"2011","unstructured":"Habib AA, Mitsumoto H (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opin Emerg Drugs 16:537\u2013558","journal-title":"Expert Opin Emerg Drugs"},{"key":"89_CR28","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1158\/1078-0432.CCR-11-0098","volume":"17","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Wall BA, Wangari-Talbot J et al (2011) Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies. Clin Cancer Res 17:7080\u20137092","journal-title":"Clin Cancer Res"},{"key":"89_CR29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-009-0613-1","volume":"132","author":"A Stepulak","year":"2009","unstructured":"Stepulak A, Luksch H, Gebhardt C et al (2009) Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 132:435\u2013445","journal-title":"Histochem Cell Biol"},{"key":"89_CR30","doi-asserted-by":"crossref","unstructured":"Speyer CL, Smith JS, Banda M, Devries JA, Mekani T, Gorski DH (2012) Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 132:565\u2013573","DOI":"10.1007\/s10549-011-1624-x"},{"key":"89_CR31","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-08-3303","volume":"15","author":"D Yip","year":"2009","unstructured":"Yip D, Le MN, Chan JL et al (2009) A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 15:3896\u20133902","journal-title":"Clin Cancer Res"},{"key":"89_CR32","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1073\/pnas.121179198","volume":"98","author":"EA Cavalheiro","year":"2001","unstructured":"Cavalheiro EA, Olney JW (2001) Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci USA 98:5947\u20135948","journal-title":"Proc Natl Acad Sci USA"},{"key":"89_CR33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2011.07.003","volume":"309","author":"K Yasui","year":"2011","unstructured":"Yasui K, Oketa Y, Higashida K, Fukazawa H, Ono S (2011) Increased progranulin in the skin of amyotrophic lateral sclerosis: an immunohistochemical study. J Neurol Sci 309:110\u2013114","journal-title":"J Neurol Sci"},{"key":"89_CR34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.08.026","volume":"298","author":"T Watanabe","year":"2010","unstructured":"Watanabe T, Okeda Y, Yamano T, Ono S (2010) An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. J Neurol Sci 298:52\u201356","journal-title":"J Neurol Sci"},{"key":"89_CR35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0447.2010.01553.x","volume":"122","author":"M Suzuki","year":"2010","unstructured":"Suzuki M, Mikami H, Watanabe T et al (2010) Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 122:367\u2013372","journal-title":"Acta Neurol Scand"},{"key":"89_CR36","doi-asserted-by":"crossref","unstructured":"Nomura M, Oketa Y, Yasui K, Ishikawa H, Ono S (2012) Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 125:389\u2013397","DOI":"10.1111\/j.1600-0404.2011.01579.x"},{"key":"89_CR37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/CBM-2011-0164","volume":"9","author":"T Bogenrieder","year":"2010","unstructured":"Bogenrieder T, Herlyn M (2010) The molecular pathology of cutaneous melanoma. Cancer Biomark 9:267\u2013286","journal-title":"Cancer Biomark"},{"key":"89_CR38","first-page":"81","volume":"17","author":"SY Park","year":"2007","unstructured":"Park SY, Lee SA, Han IH et al (2007) Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma. Oncol Rep 17:81\u201387","journal-title":"Oncol Rep"},{"key":"89_CR39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ijc.24044","volume":"124","author":"JS Kasper","year":"2009","unstructured":"Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124:1398\u20131403","journal-title":"Int J Cancer"},{"key":"89_CR40","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/ijc.24202","volume":"124","author":"MA Rowlands","year":"2009","unstructured":"Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124:2416\u20132429","journal-title":"Int J Cancer"},{"key":"89_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17482960802160370","volume":"10","author":"SA Sakowski","year":"2009","unstructured":"Sakowski SA, Schuyler AD, Feldman EL (2009) Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:63\u201373","journal-title":"Amyotroph Lateral Scler"},{"key":"89_CR42","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","volume":"71","author":"EJ Sorenson","year":"2008","unstructured":"Sorenson EJ, Windbank AJ, Mandrekar JN et al (2008) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71:1770\u20131775","journal-title":"Neurology"},{"key":"89_CR43","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1097\/00001756-200108080-00048","volume":"12","author":"MM Bilak","year":"2001","unstructured":"Bilak MM, Kuncl RW (2001) Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons. NeuroReport 12:2531\u20132535","journal-title":"NeuroReport"},{"key":"89_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000321930","volume":"36","author":"B Marin","year":"2011","unstructured":"Marin B, Couratier P, Preux PM, Logroscino G (2011) Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 36:29\u201338","journal-title":"Neuroepidemiology"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-0089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-012-0089-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-0089-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:06:17Z","timestamp":1559221577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-012-0089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s10552-012-0089-5","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,23]]}}}